MacManus J P
Cancer Res. 1981 Mar;41(3):974-9.
An antiserum has been developed against a M.W. 11,500 calcium-binding protein purified to homogeneity from Morris hepatoma 5123tc. The antiserum was specific and did not cross-react with an excess of two other calcium-binding proteins, calmodulin or parvalbumin. The amount of the tumor protein has been quantitated immunologically in several Morris hepatomas, early neoplastic liver nodules, and mouse sarcomas. This protein could not be detected in any normal rat tissue. The calcium-binding protein in mouse tumors appeared similar to that in rats by both crossed polyacrylamide gel electrophoresis-immunoelectrophoresis and crossed isoelectric focusing immunoelectrophoresis.
已制备出一种抗血清,其针对的是从莫里斯肝癌5123tc中纯化至同质的分子量为11,500的钙结合蛋白。该抗血清具有特异性,不会与过量的其他两种钙结合蛋白,即钙调蛋白或小白蛋白发生交叉反应。已通过免疫方法对几种莫里斯肝癌、早期肿瘤性肝结节和小鼠肉瘤中的肿瘤蛋白量进行了定量。在任何正常大鼠组织中均未检测到这种蛋白。通过交叉聚丙烯酰胺凝胶电泳-免疫电泳和交叉等电聚焦免疫电泳发现,小鼠肿瘤中的钙结合蛋白与大鼠中的相似。